cathepsin C Inhibitors

Cathepsin C, also known as dipeptidyl peptidase I (DPPI), is a lysosomal cysteine protease that plays a crucial role in the processing and activation of several other lysosomal proteases, particularly the cathepsin family enzymes. This proteolytic activation is essential for the normal functioning of various cellular processes, including protein degradation, immune response regulation, and tissue remodeling. Cathepsin C is synthesized as an inactive precursor and undergoes autocatalytic processing to generate the mature and active enzyme. One of its primary functions is to cleave dipeptides from the N-terminus of other cathepsin precursors, removing an inhibitory propeptide and thereby converting them into their enzymatically active forms. Inhibition of cathepsin C can disrupt the activation of lysosomal proteases and subsequently impact the cellular proteolytic machinery. While the mechanisms of inhibition can vary, they often involve targeting the active site of cathepsin C or interfering with its autocatalytic processing. Inhibition can lead to the accumulation of inactive cathepsin precursors and a subsequent reduction in the activity of downstream cathepsin enzymes. This disruption of protease activation can have far-reaching consequences on cellular processes, including protein degradation, antigen presentation, and immune response regulation. Understanding the role of cathepsin C and its inhibition is crucial for unraveling the complex interplay of lysosomal proteases and their impact on cellular homeostasis and immune function.